Primary Contact
Mark A. Edgar, M.D.
Dr. Edgar is board certified in Anatomic Pathology and Neuropathology and holds additional sub-specialty expertise in Soft Tissue/Bones/Joints Pathology. Dr. Edgar has a special interest in tumors of the nervous system, bone and soft tissue, and his principal expertise is in the diagnosis of tumors and tumor-like conditions affecting these areas.
Full Bio
Why CellNetix?
- Two board certified pathologists with expertise in Soft Tissue/Bones/Joints Pathology
- 94% of our biopsy results are returned within 48 hours
- 24/7 priority access to your local pathologists
- Reports convey information clearly, concisely and correctly
- State-of-the-art Information Technology systems with EMR interface capabilities
- Full service billing department for direct billing of patient insurance, as well as payment plans for cash-paying patients
- Customizable test requisitions
Caring for patients with bone and soft tissue tumors requires a team approach, and CellNetix Pathologists work closely with a dedicated group of specialized radiologists, musculoskeletal oncologists, and orthopedic oncologic surgeons to arrive at diagnoses. Soft tissue includes muscles, tendons, connective tissues, fat, blood vessels, nerves, and synovial (joint) tissues.
Our Strengths
CellNetix’ quality program mandates that all new cancers are reviewed by a second pathologist for quality assurance. Our state-of-the-art bar-coding system has been shown to reduce common histologic slide identification errors by 95% and overall case identification errors by 62%.
- Two board certified pathologists with expertise in Soft Tissue/Bones/Joints Pathology
- 94% of our biopsy results are returned within 48 hours
- 24/7 priority access to your local pathologists
- Reports convey information clearly, concisely and correctly
- State-of-the-art Information Technology systems with EMR interface capabilities
- Full service billing department for direct billing of patient insurance, as well as payment plans for cash-paying patients
- Customizable test requisitions
Types of Testing We Do
- Immunohistochemistry helps characterize sarcomas and benign tumor-like conditions affecting bone and soft tissue
-
Molecular diagnostic techniques pinpoint genetic abnormalities common in bone and soft tissue tumors and aid subclassification
Types of Diseases and Conditions We Test For
- Soft Tissue Sarcomas (e.g. liposarcoma, leiomyosarcoma, synovial sarcoma)
-
Benign Tumors of Soft Tissue and Joints (e.g. synovial chondromatosis)
-
Bone Cancer (e.g. osteosarcoma, chondrosarcoma)
-
Benign Bone Tumors (e.g. osteoid osteoma)
-
Gastrointestinal Stromal Tumors
-
Arthritis (e.g. reheumatoid arthritis, osteoarthritis)
References
van Villet et al. Soft tissue sarcomas at a glance: clinical, histological, and MR imaging features of malignant extremity soft tissue tumors. Eur Radiol. 2009 Jun; 19(6):1499-511
Osuna D and de Alva E. Molecular pathology of sarcomas. Rev Recent Clin Trials. 2009 Jan; 4(1): 12-26.

